Urgent Message: This study confirms variable prescription rates among different ethnicities in Aotearoa, New Zealand, for COVID-19 antiviral medication despite efforts to reduce health inequities. M. Adrianne Pimentel, MBChB, MHlthLd, FRNZCUC Key Words: Antiviral Prescribing, COVID-19, Comorbidity Abstract Introduction: In Aotearoa, New Zealand, COVID-19 disproportionately increased mortality and morbidity outcomes in Māori and Pacific patients. In an effort to counteract these health inequities, the government aimed to increase access to COVID-19 antiviral medication for Māori …
Read More